These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33855214)

  • 21. Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes.
    Hathout EH; McClintock T; Sharkey J; Kytsenko D; Hartwick N; Hadley-Scofield M; Torgeson S; Mace JW
    Diabetes Technol Ther; 2003; 5(2):175-81. PubMed ID: 12871607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Weight Change, Clinical Outcomes, and Health Care Costs in Patients with Type 2 Diabetes.
    Mukherjee J; Sternhufvud C; Smith N; Bell K; Stott-Miller M; McMorrow D; Johnston S
    J Manag Care Spec Pharm; 2016 May; 22(5):449-66. PubMed ID: 27123909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes and resource use after 24 months of insulin therapy in Turkish patients with type 2 diabetes: subgroup analysis of the TREAT study.
    Oguz A; Cevizci E; Ertekin A; Abdulnabi R;
    Int J Clin Pract; 2015 May; 69(5):588-96. PubMed ID: 25472768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weight change in patients with type 2 diabetes starting basal insulin therapy: correlates and impact on outcomes.
    Shaefer CF; Reid TS; Dailey G; Mabrey ME; Vlajnic A; Stuhr A; Stewart J; Zhou R
    Postgrad Med; 2014 Oct; 126(6):93-105. PubMed ID: 25414938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.
    Yoon NM; Cavaghan MK; Brunelle RL; Roach P
    Clin Ther; 2009 Jul; 31(7):1511-23. PubMed ID: 19695400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of change in glycosylated haemoglobin to insulin-associated weight gain: results of a longitudinal study in type 2 diabetic patients.
    Jansen HJ; Hendriks JC; de Galan BE; Penders G; Tack CJ; Vervoort G
    Endocrine; 2011 Apr; 39(2):190-7. PubMed ID: 21069577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents.
    Home PD; Dain MP; Freemantle N; Kawamori R; Pfohl M; Brette S; Pilorget V; Scherbaum WA; Vespasiani G; Vincent M; Balkau B
    Diabetes Res Clin Pract; 2015 May; 108(2):350-9. PubMed ID: 25825361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.
    Yu AP; Wu EQ; Birnbaum HG; Emani S; Fay M; Pohl G; Wintle M; Yang E; Oglesby A
    Curr Med Res Opin; 2007 Sep; 23(9):2157-69. PubMed ID: 17669232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight and glycaemic control in type 2 diabetes: what is the outcome of insulin initiation?
    Watson L; Wilson BP; Alsop J; Kumar S
    Diabetes Obes Metab; 2011 Sep; 13(9):823-31. PubMed ID: 21481128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetes.
    Bell DS; Ovalle F
    Diabetes Obes Metab; 2006 Jan; 8(1):110-5. PubMed ID: 16367889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Start of insulin therapy in patients with type 2 diabetes mellitus promotes the influx of macrophages into subcutaneous adipose tissue.
    Jansen HJ; Stienstra R; van Diepen JA; Hijmans A; van der Laak JA; Vervoort GM; Tack CJ
    Diabetologia; 2013 Dec; 56(12):2573-81. PubMed ID: 24065152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study.
    Meneghini LF; Dornhorst A; Sreenan S;
    Curr Med Res Opin; 2009 Apr; 25(4):1029-35. PubMed ID: 19281426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can an electronic glycaemic notebook associated with an insulin calculator improve HbA1c in diabetic patients on a multiple insulin injections regimen? A 26-week observational real-life study.
    Oriot P; Ponchon M; Hermans MP
    Acta Clin Belg; 2016 Feb; 71(1):51-6. PubMed ID: 27150670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the relationship between weight change and glycemic control after initiation of antidiabetic therapy in patients with type 2 diabetes using electronic medical record data.
    McAdam-Marx C; Mukherjee J; Bellows BK; Unni S; Ye X; Iloeje U; Brixner DI
    Diabetes Res Clin Pract; 2014 Mar; 103(3):402-11. PubMed ID: 24503045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT).
    de Wit HM; Vervoort GM; Jansen HJ; de Grauw WJ; de Galan BE; Tack CJ
    Diabetologia; 2014 Sep; 57(9):1812-9. PubMed ID: 24947583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of body weight in type 2 diabetes.
    Chaudhry ZW; Gannon MC; Nuttall FQ
    Diabetes Care; 2006 Mar; 29(3):493-7. PubMed ID: 16505494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutically interchangeable? A study of real-world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records data.
    Levin P; Wei W; Miao R; Ye F; Xie L; Baser O; Gill J
    Diabetes Obes Metab; 2015 Mar; 17(3):245-53. PubMed ID: 25359227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pronounced weight gain in insulin-treated patients with type 2 diabetes mellitus is associated with an unfavourable cardiometabolic risk profile.
    Jansen HJ; Vervoort G; van der Graaf M; Tack CJ
    Neth J Med; 2010 Nov; 68(11):359-66. PubMed ID: 21116029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with weight gain in people with type 2 diabetes starting on insulin.
    Balkau B; Home PD; Vincent M; Marre M; Freemantle N
    Diabetes Care; 2014 Aug; 37(8):2108-13. PubMed ID: 24824546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.